Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Zofran Linked to Hypospadia in Study Published in 2004

Zofran Linked to Hypospadia in Study Published in 2004

April 7, 2015 — Nearly a decade ago, a study found case reports linking the use of Zofran during pregnancy and a birth defect known as hypospadia, but this risk was never investigated by GlaxoSmithKline (GSK).

Zofran has been on the market since the early 1990s, but its safety in pregnant women has never been evaluated by GSK.

One of the first studies to investigate the risk of birth defects was published in September 2004, but it was based on only 176 women who used Zofran in the first trimester. The study was not large enough to make any conclusions about specific birth defects.

After excluding pregnancies that did not come to term, six women (3.6%) had babies with “major” birth defects — including three babies who were born with hypospadia and needed surgery.

The number of cases of hypospadia was unusually high, considering that the defect normally only occurs in 1 out of 300 births. The researchers warned:

“[Zofran] was never intended or labeled as such to be a treatment for NVP. Consequently, there is a paucity of data in the literature on the safety of [Zofran].”

The study was published by the medical journal BJOG: an International Journal of Obstetrics and Gynaecology, and titled “The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.”

Hypospadia is a serious birth defect that involves a urethral opening somewhere other than at the tip of the penis. It almost always requires surgery. Without treatment, boys with hypospadia may have to urinate sitting down and they may have sexual dysfunction as adults.

Do I have a Zofran Lawsuit?

The Schmidt Firm, PLLC is currently accepting Zofran induced injury cases in all 50 states. If your child or a loved one was diagnosed with a hypospadia or other birth defect, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiff’s law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*